Sciclone Pharma (SCLN) Enters Settlement Over FCPA Violation Allegations; Will Evaluate Alternatives
Tweet Send to a Friend
SciClone Pharmaceuticals, Inc. (Nasdaq: SCLN) announced it has entered into a settlement agreement with the United States Securities and Exchange ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
